Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers

作     者：Kadri Altundag Qiu-Wen Tan Ting Luo Hong Zheng Ting-Lun Tian Ping He Jie Chen He-Lin Zeng Qing Lv 

作者机构：MKA Breast Cancer Clinic Tepe Prime Cankaya 06800 Ankara Turkey Department of Breast Surgery West China Hospi-tal Sichuan University Chengdu Sichuan 610041 P. R. China Department of Medical Oncology West China Hospi-tal Sichuan University Chengdu Sichuan 610041 P. R. China 

出 版 物：《Chinese Journal of Cancer》 (Chinese Journal of Cancer)

年 卷 期：2017年第36卷第6期

页      面：282-283页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：乳腺癌 晚期 病理 阳性 阴性 治疗方案 Tan PCR 

摘      要：To The Editor I want to congratulate *** and colleagues for their article entitled Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer:a randomized controlled trial [1].The pathologic complete response(pCR)rate was similar in the two arms(10.61%vs.12.31%,P=0.665).However,the